Ms. Malcolm is an accomplished leader in health policy, public health, and health care finance and delivery. She has demonstrated a career-long dedication to improving the health of the public and the care of complex populations. Twice Minnesota’s Commissioner of Health under three governors representing two political parties (from 1999-2003 and from 2018 until her retirement in January 2023), Ms. Malcolm earned a national reputation as one of the first health care leaders to highlight health disparities and the impact of social determinants of health.
As Health Commissioner during the COVID-19 pandemic, she also played an instrumental and visible role in educating the public, creating dynamic and user-friendly systems for sharing COVID-19 data with the people of Minnesota, and rapidly expanding testing capacity. Prior to the COVID-19 pandemic, the Minnesota Department of Health had a budget of over $600 million per year from all funding sources, and employed over 1,500 highly professional staff. During the pandemic the budget and staffing more than doubled with federal funds, staff re-deployments, and temporary contractors. In recognition of her many accomplishments, in February 2024 the American Medical Association (AMA) presented Ms. Malcolm with the AMA Award for Outstanding Government Service.
Prior to being re-appointed Commissioner in 2018, Ms. Malcolm was an adjunct faculty member at the University of Minnesota School of Public Health, where she co-directed a national research and leadership development program funded by the Robert Wood Johnson Foundation. Ms. Malcolm also served as vice president of the Allina Health system from 1994 to 1999 and 2013 to 2016, with responsibilities spanning corporate communications, public affairs, government relations, health policy, community relations, and philanthropy. From 2005 to 2013, she served as CEO of the Courage Center, a leading provider of rehabilitation and health services for people with disabilities serving over 12,000 patients annually.
Ms. Malcolm received a bachelor’s degree in philosophy and psychology from Dartmouth College.
What is Jan Malcolm's net worth?
The estimated net worth of Jan Malcolm is at least $251.73 thousand as of September 9th, 2025. Malcolm owns 520 shares of United Therapeutics stock worth more than $251,732 as of December 4th. This net worth approximation does not reflect any other assets that Malcolm may own. Learn More about Jan Malcolm's net worth.
How do I contact Jan Malcolm?
Has Jan Malcolm been buying or selling shares of United Therapeutics?
Jan Malcolm has not been actively trading shares of United Therapeutics within the last three months. Most recently, Jan Malcolm sold 700 shares of the business's stock in a transaction on Tuesday, September 9th. The shares were sold at an average price of $400.29, for a transaction totalling $280,203.00. Following the completion of the sale, the director now directly owns 520 shares of the company's stock, valued at $208,150.80. Learn More on Jan Malcolm's trading history.
Who are United Therapeutics' active insiders?
United Therapeutics' insider roster includes Michael Benkowitz (COO), Christopher Causey (Director), Raymond Dwek (Director), James Edgemond (CFO), Richard Giltner (Director), Paul Mahon (EVP), Jan Malcolm (Director), Nilda Mesa (Director), Judy Olian (Director), Christopher Patusky (Director), Martine Rothblatt (CEO), Louis Sullivan (Director), and Tommy Thompson (Director). Learn More on United Therapeutics' active insiders.
Are insiders buying or selling shares of United Therapeutics?
During the last twelve months, insiders at the biotechnology company sold shares 92 times. They sold a total of 892,280 shares worth more than $364,227,874.83. The most recent insider tranaction occured on December, 1st when CFO James Edgemond sold 21,000 shares worth more than $10,079,790.00. Insiders at United Therapeutics own 10.3% of the company.
Learn More about insider trades at United Therapeutics. Information on this page was last updated on 12/1/2025.
